MA45451A - Formulations tensioactives destinées à l'inhalation - Google Patents
Formulations tensioactives destinées à l'inhalationInfo
- Publication number
- MA45451A MA45451A MA045451A MA45451A MA45451A MA 45451 A MA45451 A MA 45451A MA 045451 A MA045451 A MA 045451A MA 45451 A MA45451 A MA 45451A MA 45451 A MA45451 A MA 45451A
- Authority
- MA
- Morocco
- Prior art keywords
- tensioactive
- inhalation
- formulations intended
- formulations
- intended
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0082—Lung surfactant, artificial mucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662354382P | 2016-06-24 | 2016-06-24 | |
| US201662420932P | 2016-11-11 | 2016-11-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA45451A true MA45451A (fr) | 2019-05-01 |
Family
ID=59295343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA045451A MA45451A (fr) | 2016-06-24 | 2017-06-23 | Formulations tensioactives destinées à l'inhalation |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20190388444A1 (fr) |
| EP (1) | EP3474832B1 (fr) |
| JP (2) | JP7240178B2 (fr) |
| AU (2) | AU2017281931B2 (fr) |
| CA (1) | CA3028724A1 (fr) |
| ES (1) | ES3069827T3 (fr) |
| MA (1) | MA45451A (fr) |
| MX (2) | MX2018015969A (fr) |
| WO (1) | WO2017223502A1 (fr) |
| ZA (1) | ZA201900337B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017281931B2 (en) * | 2016-06-24 | 2023-02-02 | Merz Pharmaceuticals, Llc | Surfactant formulations for inhalation |
| MX2020006634A (es) * | 2017-12-21 | 2021-01-15 | Civitas Therapeutics Inc | Formulaciones de surfactantes para inhalacion. |
| CA3085943A1 (fr) * | 2017-12-21 | 2019-06-27 | Civitas Therapeutics, Inc. | Formulations de tensioactifs inhalables |
| WO2022082082A2 (fr) * | 2020-10-16 | 2022-04-21 | Sherwood Russ Lehrman | Compositions de traitement pulmonaire |
| WO2023281523A1 (fr) * | 2021-07-09 | 2023-01-12 | Indian Council Of Medical Research | Composition pharmaceutique comprenant un fragment recombinant de la protéine tensioactive d humaine pour une infection par le sars-cov-2 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4069819A (en) | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
| IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
| CZ292186B6 (cs) * | 1996-01-24 | 2003-08-13 | Altana Pharma Ag | Způsob výroby práškového prostředku s obsahem plicní povrchově aktivní látky, práškový prostředek a jeho použití |
| CA2382821A1 (fr) * | 1999-08-25 | 2001-03-01 | Advanced Inhalation Research, Inc. | Modulation de liberation a partir de formulations seches en poudre |
| US6586008B1 (en) * | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
| JP2003522138A (ja) * | 2000-02-11 | 2003-07-22 | アルタナ ファルマ アクチエンゲゼルシャフト | 慢性肺疾患の予防および治療のための肺表面活性剤の新規使用 |
| WO2007084136A2 (fr) * | 2006-01-23 | 2007-07-26 | Ony, Inc. | Traitement du sras |
| CN101448405B (zh) * | 2006-03-22 | 2013-03-06 | Wm.雷格利Jr.公司 | 压缩的口香糖及其制备方法 |
| WO2008011559A2 (fr) | 2006-07-20 | 2008-01-24 | University Of Rochester | Tensioactif pulmonaire synthetique et utilisation associée |
| WO2008016497A2 (fr) * | 2006-07-31 | 2008-02-07 | Corn Products International, Inc. | Compositions d'isomaltitol et procédé de fabrication de compositions d'isomaltitol |
| US8496002B2 (en) | 2007-06-12 | 2013-07-30 | Civitas Therapeutics, Inc. | Powder inhaler devices |
| WO2009026434A1 (fr) * | 2007-08-21 | 2009-02-26 | Alkermes, Inc. | Formulations pharmaceutiques pulmonaires |
| AU2017281931B2 (en) * | 2016-06-24 | 2023-02-02 | Merz Pharmaceuticals, Llc | Surfactant formulations for inhalation |
-
2017
- 2017-06-23 AU AU2017281931A patent/AU2017281931B2/en active Active
- 2017-06-23 CA CA3028724A patent/CA3028724A1/fr active Pending
- 2017-06-23 MA MA045451A patent/MA45451A/fr unknown
- 2017-06-23 WO PCT/US2017/039094 patent/WO2017223502A1/fr not_active Ceased
- 2017-06-23 JP JP2018567655A patent/JP7240178B2/ja active Active
- 2017-06-23 EP EP17736843.8A patent/EP3474832B1/fr active Active
- 2017-06-23 MX MX2018015969A patent/MX2018015969A/es unknown
- 2017-06-23 ES ES17736843T patent/ES3069827T3/es active Active
-
2018
- 2018-12-18 MX MX2023012602A patent/MX2023012602A/es unknown
- 2018-12-21 US US16/228,955 patent/US20190388444A1/en not_active Abandoned
-
2019
- 2019-01-17 ZA ZA201900337A patent/ZA201900337B/en unknown
-
2022
- 2022-08-22 US US17/892,436 patent/US20240016823A1/en active Pending
-
2023
- 2023-03-03 JP JP2023033133A patent/JP7629159B2/ja active Active
- 2023-03-31 AU AU2023201990A patent/AU2023201990B9/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20240016823A1 (en) | 2024-01-18 |
| JP7240178B2 (ja) | 2023-03-15 |
| AU2017281931A1 (en) | 2019-01-17 |
| CA3028724A1 (fr) | 2017-12-28 |
| JP7629159B2 (ja) | 2025-02-13 |
| US20190388444A1 (en) | 2019-12-26 |
| EP3474832B1 (fr) | 2026-03-18 |
| AU2017281931B2 (en) | 2023-02-02 |
| EP3474832C0 (fr) | 2026-03-18 |
| MX2018015969A (es) | 2019-06-10 |
| NZ749513A (en) | 2024-09-27 |
| AU2023201990A1 (en) | 2023-05-04 |
| JP2019518782A (ja) | 2019-07-04 |
| AU2023201990B2 (en) | 2025-05-01 |
| JP2023071886A (ja) | 2023-05-23 |
| ZA201900337B (en) | 2019-10-30 |
| WO2017223502A1 (fr) | 2017-12-28 |
| ES3069827T3 (en) | 2026-06-10 |
| MX2023012602A (es) | 2023-11-03 |
| AU2023201990B9 (en) | 2025-05-08 |
| EP3474832A1 (fr) | 2019-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3430731A4 (fr) | Architecture d'iugw | |
| EP3509681A4 (fr) | Mécanisme de réinitialisation d'un inhalateur | |
| EP3437540A4 (fr) | Support d'endoscope | |
| EP2968137A4 (fr) | Formulations d'émulsion | |
| IL281425A (en) | Nanoparticle formulations | |
| EP3412344A4 (fr) | Composition d'agent extincteur | |
| MA42771A (fr) | Chaussure perméable à l'air | |
| EP3556368A4 (fr) | Agent thérapeutique contre l'onychomycose | |
| PL3629098T3 (pl) | Kaseta wywołująca | |
| EP3378606A4 (fr) | Combinaison d'assistance | |
| EP3463259A4 (fr) | Compositions d'écran solaire | |
| EP3525841C0 (fr) | Micro-dispositif d'administration | |
| EP3522872A4 (fr) | Formulations d'amlodipine | |
| EP3351561A4 (fr) | Dérivé d'adrénomédulline à action prolongée | |
| EP3302061A4 (fr) | Compositions d'urée à libération prolongée | |
| EP3525479A4 (fr) | Casque d'écoute | |
| EP3482698A4 (fr) | Instrument d'hémostase | |
| EP3399965A4 (fr) | Formulations d'undécanoate de testostérone proliposomales | |
| EP3431808A4 (fr) | Butée d'arrêt | |
| EP3512503A4 (fr) | Formulations liposomales | |
| EP3443854A4 (fr) | Inhalateur d'arôme | |
| ZA201900337B (en) | Surfactant formulations for inhalation | |
| EP3512518A4 (fr) | Arrière-plan de l'invention de formulations de buprénorphine à libération prolongée | |
| EP3525772A4 (fr) | Formulations destinées à l'administration entérique d'agents thérapeutiques | |
| EP3429581A4 (fr) | Formulations d'énalapril |